Life years lost due to cardiovascular diseases

Irena Maniecka-Bryła1, Małgorzata Pikala, Marek Bryła

  • 1Department of Epidemiology and Biostatistics, Medical University of Lodz, Lodz, Poland. irena.maniecka-bryla@umed.lodz.pl.

Kardiologia Polska
|November 8, 2013
PubMed

Insights

Cardiovascular disease (CVD) significantly impacts life expectancy, causing substantial years of life lost. Ischaemic heart disease (IHD) and cerebrovascular disease were major contributors in the Lodz region, with concerning trends observed.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiology

Background:

  • Premature mortality measures, such as years of life lost, are crucial for population health assessment.
  • Cardiovascular diseases (CVD) represent a leading cause of premature death and significant loss of life years.

Purpose of the Study:

  • To quantify life years lost due to CVD in the Lodz region.
  • To identify specific CVDs causing the most life years lost and analyze trends from 1999-2008.

Main Methods:

  • Analysis of 146,852 CVD-related death certificates from the Lodz region (1999-2008).
  • Calculation of Standard Expected Years of Life Lost per person (SEYLLp) and per death (SEYLLd).
  • Application of Joinpoint models to analyze temporal trends and estimate average annual percentage changes.

Main Results:

  • In 2008, life years lost were 754/10,000 males and 595/10,000 females.
  • Males: Ischaemic heart disease (IHD) (SEYLLp=200), particularly acute myocardial infarction (AMI) (SEYLLp=128), and other heart diseases (SEYLLp=199) were primary causes.
  • Females: Cerebrovascular disease (SEYLLp=176) and other heart diseases (SEYLLp=152) were the leading causes of life years lost.

Conclusions:

  • IHD was the leading cause of life years lost in males, while cerebrovascular disease predominated in females.
  • An increasing trend in CVD-related life years lost was observed from 2002/2003, decelerating after 2006.
  • IHD showed the most significant decrease in life years lost for both sexes between 1999 and 2008.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627